Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Trehalose Dihydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ALYMSYS

    02 1BLINCYTO

    03 2COSENTYX

    04 1TANZEUM

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    AMGEN

    BLINATUMOMAB

    arrow
    Health 2.0 Conference
    Not Confirmed
    AMGEN
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BLINATUMOMAB

    Drug : BLINCYTO

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 125557

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AMNEAL PHARMS LLC

    BEVACIZUMAB-MALY

    arrow
    Health 2.0 Conference
    Not Confirmed
    AMNEAL PHARMS LLC
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BEVACIZUMAB-MALY

    Drug : ALYMSYS

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 761231

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    GLAXOSMITHKLINE LLC

    ALBIGLUTIDE

    arrow
    Health 2.0 Conference
    Not Confirmed
    GLAXOSMITHKLINE LLC
    United Kingdom
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ALBIGLUTIDE

    Drug : TANZEUM

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 125431

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NOVARTIS PHARMS CORP

    SECUKINUMAB

    arrow
    Health 2.0 Conference
    Not Confirmed
    NOVARTIS PHARMS CORP
    Switzerland
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SECUKINUMAB

    Drug : COSENTYX

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 761349

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NOVARTIS PHARMS CORP

    SECUKINUMAB

    arrow
    Health 2.0 Conference
    Not Confirmed
    NOVARTIS PHARMS CORP
    Switzerland
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SECUKINUMAB

    Drug : COSENTYX

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 125504

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.